Saxén H, Hakkarainen K, Pohjavuori M, Miettinen A
Children's Hospital, University of Helsinki, Finland.
Acta Paediatr. 1993 Feb;82(2):198-201. doi: 10.1111/j.1651-2227.1993.tb12638.x.
The occurrence of Ureaplasma urealyticum and Mycoplasma hominis in the airways and the association of these microorganisms with chronic lung disease was studied in preterm infants with a gestational age less than 30 weeks. Tracheal aspirates from 49 preterm infants were cultured; 14 (29%) infants were positive for U. urealyticum, and 1 (2%) was positive for M. hominis. Of the 16 patients who developed lung disease, 6 (38%) were positive for U. urealyticum, while the expected number of Ureaplasma-positive patients in this group, based on the overall incidence of Ureaplasma, was 4.6. On the other hand, 8 patients were positive for U. urealyticum but did not develop chronic lung disease, nor did samples taken from 10 patients with chronic lung disease show any Ureaplasma growth. From these data we conclude that colonization of the airways with U. urealyticum has no significant role in the development of chronic lung disease in preterm infants in the Finnish (Caucasian) population.
对孕周小于30周的早产儿进行了研究,以探讨解脲脲原体和人型支原体在气道中的出现情况以及这些微生物与慢性肺病的关联。对49例早产儿的气管吸出物进行培养;14例(29%)婴儿解脲脲原体阳性,1例(2%)人型支原体阳性。在16例发生肺病的患者中,6例(38%)解脲脲原体阳性,而根据解脲脲原体的总体发生率,该组中解脲脲原体阳性患者的预期数量为4.6例。另一方面,8例解脲脲原体阳性患者未发生慢性肺病,10例慢性肺病患者的样本也未显示解脲脲原体生长。根据这些数据我们得出结论,在芬兰(高加索)人群的早产儿中,气道解脲脲原体定植在慢性肺病的发生中没有显著作用。